Taipei, Taiwan

Yu-Ching Lee

USPTO Granted Patents = 11 


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • New Taipei, TW (2017)
  • New Taipei, CN (2020 - 2022)
  • Taipei, TW (2011 - 2023)

Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
11 patents (USPTO):

Title: Innovations and Contributions of Inventor Yu-Ching Lee

Introduction

Yu-Ching Lee is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for cancer detection and treatment. With a total of 11 patents to his name, Lee's work has the potential to impact medical diagnostics and therapeutic strategies.

Latest Patents

One of Yu-Ching Lee's latest patents involves the creation of anti-EGF like domain multiple 6 (EGFL6) antibodies. This invention relates to the use of anti-EGFL6 antibodies for cancer detection and treatment. The antibodies developed in this patent, particularly single-chain antibody fragments (scFv) and humanized antibodies, demonstrate the ability to bind to EGFL6, inhibiting angiogenesis and cancer cell growth. Another significant patent focuses on antibodies against infectious diseases, providing anti-CaENO1 antibodies and humanized antibodies as effective diagnostic agents or therapeutic treatments against infections.

Career Highlights

Throughout his career, Yu-Ching Lee has worked with notable institutions such as Taipei Medical University and Accelstor Ltd. His research and innovations have garnered attention in the scientific community, contributing to advancements in medical technology.

Collaborations

Yu-Ching Lee has collaborated with esteemed colleagues, including Sy-Jye Leu and Yi-Yuan Yang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

In summary, Yu-Ching Lee is an influential inventor whose work in antibody development has the potential to revolutionize cancer treatment and diagnostics. His contributions to biotechnology continue to pave the way for innovative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…